Rejection, Transplant Completed Phase 2 Trials for Tacrolimus (DB00864)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117689Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionPrevention